Sanofi to acquire U.S.-based Translate Bio in deal valued at $3.2 billion
French healthcare major Sanofi has agreed to acquire Translate Bio Inc. in a deal that gives the mRNA-therapeutics company a total equity value of around $3.2 billion.
The two companies, which have been working on a mRNA Covid-19 vaccine candidate together, said on Tuesday that Sanofi would acquire all of Translate Bio's outstanding shares for $38.00 a share in cash. The price represents a premium of 56% to Translate Bio's volume-weighted average price a share of the past 60 days, they said.
The boards of directors of both companies approved the deal and Translate Bio's chief executive officer and its largest shareholder The Baupost Group, LLC have agreed to support the offer, the companies said. "Our goal is to unlock the potential of mRNA in other strategic areas such as immunology, oncology, and rare diseases in addition to vaccines," Sanofi Chief Executive Paul Hudson said.
Sanofi's tender offer is planned to start later this month and it expects the takeover of the U.S. company to be completed in the third quarter.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Kevin Smith Bio-Documentary ‘Clerk’ Gets Fall Release Date In 1091 Pictures DealEXCLUSIVE: 1091 Pictures has acquired rights to Clerk, the Malcolm Ingram-directed feature documentary about the life and career of filmmaker (and many other things) Kevin Smith. The pic, which had…
Read more »
Here’s the trick to buying a new house while selling the old oneIt's hard enough buying a house these days, and if you sell your house before buying, you might end up with nowhere to go.
Read more »
Must Read: The Weeknd Covers 'GQ''s First-Ever Global Edition, Demna Gvasalia Named Creative Director for Kanye West's Donda ReleaseHow the Brazilian butt lift went mainstream:
Read more »
10 stock picks to buy, top recommendations, high-conviction buys: MSMorgan Stanley says these 10 stocks are the firm's top selections right now in a group of picks that's doubled the S&P 500 over the last 3 years
Read more »
Jack Dorsey's Square to buy Afterpay for $29 billion in stockBusiness Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Read more »
Square to buy Australia's Afterpay in $29 billion deal as 'buy now, pay later' trend takes offJack Dorsey's payment company announced a $29 billion, all-stock deal to buy Australia's Afterpay as the installment loan competition heats up.
Read more »